Evaluation of Treatment Outcomes in Schizophrenic Patients Taking Part in the Integrated Care Program - a Single-Country, Multi-Centre Non-Interventional Study.
Phase of Trial: Phase IV
Latest Information Update: 17 Dec 2010
At a glance
- Drugs Quetiapine (Primary)
- Indications Psychotic disorders; Schizoaffective disorder; Schizophrenia
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 17 Dec 2010 Last checked against ClinicalTrials.gov record.
- 09 Dec 2010 Actual end date (Dec 2008) added as reported by ClinicalTrials.gov.
- 30 Oct 2008 Status changed from recruiting to discontinued, based oin information from ClinicalTrials.gov. This trial was terminated as a result of difficulties associated with finding eligible sites/ patients.